Althea Group Holdings Ltd (ASX: AGH) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Althea Group Holdings Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $13.78 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 406.50 million
Earnings per share -0.085
Dividend per share N/A
Year To Date Return -12.82%
Earnings Yield N/A
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Althea Group Holdings Ltd (ASX: AGH)
    Latest News

    a woman
    Coronavirus News

    Here's how ASX cannabis shares are being impacted by COVID-19

    Althea Group Holdings Ltd (ASX:AGH) and other ASX cannabis shares have fallen heavily this month because of the coronavirus. Will…

    Read more »

    a woman
    Share Market News

    How did ASX cannabis shares perform this reporting season?

    As February reporting season wraps up, let's take a look at how these ASX cannabis shares performed.

    Read more »

    a woman
    Share Market News

    Why this ASX cannabis share is sinking lower today

    The Althea Group Holdings Ltd (ASX:AGH) share price is sinking lower today as the ASX cannabis share released its half-year…

    Read more »

    a woman
    Share Market News

    How have these 3 ASX cannabis shares kicked off 2020?

    It has been a mixed start to the year for ASX cannabis shares. We take a look at how 3…

    Read more »

    a woman
    Share Gainers

    Why Althea, Appen, Challenger, & De Grey Mining are surging higher

    The Appen Ltd (ASX:APX) share price and the Challenger Ltd (ASX:CGF) share price are two of four surging higher on…

    Read more »

    a woman
    Share Gainers

    Why this ASX cannabis share is smoking the market today

    The Althea Group Holdings Ltd (ASX:AGH) share price is on the move on Tuesday after the cannabis company provided its…

    Read more »

    a woman
    Share Gainers

    Why this ASX cannabis share jumped 12% higher today

    The MGC Pharmaceuticals Ltd (ASX:MXC) share price is jumping higher on Thursday. Here's why the cannabis company is up 12%…

    Read more »

    a woman
    Share Market News

    Why these 2 ASX cannabis shares are flying higher this week

    Shares in Cann Group Limited (ASX: CAN) and Althea Group Holdings (ASX: AGH) are flying higher this week. Here's a…

    Read more »

    a woman
    Share Market News

    ALL ORDINARIES finishes higher Tuesday: 8 ASX shares you missed

    The S&P/ASX 200 (Index:^AXJO)(ASX:XJO) and ALL ORDINARIES (Index:^AXAO) (ASX:XAO) finished up on Tuesday, here are 8 ASX shares you missed.

    Read more »

    a woman
    Share Gainers

    Why this ASX cannabis stock is soaring today

    Shares in ASX cannabis group Althea Group Holdings Ltd (ASX: AGH) are climbing higher this morning after a strong operational…

    Read more »

    a woman
    Share Market News

    What's in store for these 4 ASX cannabis shares in 2020?

    2019 was a bear market for cannabis stocks globally. We take a look at what 2020 holds for ASX cannabis…

    Read more »

    a woman
    Share Gainers

    Why Cann and these ASX shares are rocketing higher today

    The Cann Group Ltd (ASX:CAN) share price is rocketing higher on Monday. Here's why Cann and these ASX cannabis shares…

    Read more »

    AGH ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Althea Group Holdings Ltd

    Althea Group Holdings Ltd is engaged in the manufacturing, sales, and distribution of cannabis-based medicines and recreational cannabis products. It operates in three reportable segments Pharmaceutical Cannabis, Recreational Cannabis, andCorporate in which it generates the majority of its revenue from Pharmaceutical Cannabis. It operates into geographic segments: Australia, the United Kingdom, Canada, Germany and Ireland. The company earns key revenue from Australia and through the sale of medicinal cannabis products.

    AGH Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    02 Dec 2024 $0.03 $0.00 0.00% 191,552 $0.04 $0.04 $0.03
    29 Nov 2024 $0.04 $0.00 0.00% 824,049 $0.04 $0.04 $0.04
    28 Nov 2024 $0.04 $0.00 0.00% 141,654 $0.04 $0.04 $0.04
    27 Nov 2024 $0.04 $0.00 0.00% 63,306 $0.04 $0.04 $0.04
    26 Nov 2024 $0.04 $0.00 0.00% 869,514 $0.04 $0.04 $0.04
    25 Nov 2024 $0.04 $0.00 0.00% 1,002,352 $0.04 $0.04 $0.04
    22 Nov 2024 $0.04 $0.00 0.00% 178,698 $0.04 $0.04 $0.04

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    01 Nov 2024 Vaughan Webber Buy 1,000,000 $44,485
    On-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Alan Maclean Boyd Non-Executive Director Jun 2018
    Mr Boyd started his professional career in chartered accounting firms in England and Australia and has broad financial experience across many industry sectors. He is Chair of the Risk and Compliance Management Committee.
    Mr Vaughan Webber Non-Executive ChairmanNon-Executive Director Aug 2024
    Mr Webber is a company director and finance executive with over 20 years of experience, His career highlights include Non-Executive Director, HUB24 Ltd (ASX:HUB) (2012-2018), Independent Chairman, Wentworth Holdings Ltd (ASX:WWM) (2009-2013) ,Ltd (ASX:TOP) Independent Chairman, Solvar Ltd (ASX:SVR) (2014-2016), Non-Executive Director, Anchor Resources Ltd (ASX:AHR) (2011-2019). Mr Webber currently holds a number of Board roles including Chairman in the private sector.
    Mr Joshua Michael Fegan Chief Executive OfficerManaging Director Jun 2018
    Mr Fegan is the founder of Althea Group Holdings Limited and has experience in business building, sales and marketing. He has a range of business and strategy skills and has previously held a number of senior management roles at national value-based retailer, Strathfield Group.
    Penelope Dobson Non-Executive Director Nov 2018
    Ms Dobson is an experienced global healthcare executive. She has worked in the broad life-science space since her training as a pharmacist in New Zealand, including many years in the global pharmaceutical industry. She is a member of the Risk and Compliance Management Committee.
    Mr Adam John Gallagher Company Secretary Dec 2024
    -
    Mr Robert Meissner Chief Financial Officer Apr 2019
    -
    Robert Meissner Chief Financial Officer
    -
    Adam John Gallagher Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Adman Lanes Pty Ltd 60,000,000 14.76%
    Joshua Michael Fegan 57,444,030 14.13%
    UBS Nominees Pty Ltd 10,769,451 2.65%
    Citicorp Nominees Pty Limited 10,558,096 2.60%
    Mancann Pty Ltd 10,000,000 2.46%
    Hootch Pty Ltd 7,500,000 1.85%
    Hunt Prosperity Pty Ltd Investius PB Micro Cap A/C> 7,500,000 1.85%
    Hosanda Corporation Pty Limited 6,500,000 1.60%
    Mr Thomas Mark Nowak 5,000,000 1.23%
    HSBC Custody Nominees (Australia) Limited 4,807,529 1.18%
    Pither Investments Pty Ltd Pither Investments A/C> 4,800,000 1.18%
    Rizzo Super Pty Ltd Rizzo Super Fund A/C> 4,500,000 1.11%
    McLennan Trading Pty Ltd 4,100,000 1.01%
    Kevevans Pty Ltd 3,850,000 0.95%
    Vidog Capital Pty Ltd 3,770,834 0.93%
    Mr Orlando Alfredo Guerra Curvelo 3,500,000 0.86%
    Mrs Nola Kendall Fletcher 3,250,000 0.80%
    Nintieth Y Pty Ltd I K Cldwell & Co Staff A/C> 3,000,000 0.74%
    HSBC Custody Nominees (Australia) Limited A/C 2 2,952,629 0.73%
    Mr Hooi Giap Toh Yang and Toh Family A/C> 2,500,000 0.62%

    Profile

    since

    Note